HOME >> MEDICINE >> NEWS
Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

Houston May 08, 2007 -- A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.

"Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors," says review author Dr. Siqing Fu, an assistant professor of oncology at the University of Texas at Houston. "However, more research is needed to determine whether combining molecular-targeted therapy with hormonal therapy would be a more effective option."

Ovarian cancer is the deadliest of gynecological cancers; approximately 70 percent of patients are diagnosed in the later stages, when the 5-year survival rate drops below 25 percent. Traditional chemotherapy has proven to be generally ineffective against recurrent ovarian cancer, which has led researchers to investigate novel treatments.

"While a cure is unlikely, the goals of treatment are to control tumor-related symptoms and to improve or maintain quality of life," says Dr. Fu. "After surveying the latest research, combined molecular-targeted and hormonal therapy offers the greatest promise in achieving these goals and therefore deserves further investigation."


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-May-2007


Page: 1

Related medicine news :

1. Combined imaging approach may provide better identification of difficult-to-diagnose brain clots
2. Combined therapies may boost immune response and long-term protection against brain tumors
3. Combined liver-kidney transplant beneficial for patients with dual organ disease
4. Combined contrast enhanced MRI shows promise
5. Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
6. Combined MRI and mammography more effective at detecting breast cancer in high-risk women
7. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
8. Bulimia may result from hormonal imbalance
9. 1 in 5 early-stage breast cancer patients may not follow hormonal therapy plan
10. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
11. Some nonhormonal therapies may offer relief from hot flashes, but with possible adverse effects

Post Your Comments:
(Date:3/31/2015)... 31, 2015 Dr. François Blaudeau, the ... Counsel in a power morcellator lawsuit filed ... a result of metastatic leiomyosarcoma, a rare and aggressive ... which was filed by her husband and is currently ... Pennsylvania, alleges that the power morcellator used during her ...
(Date:3/31/2015)... St. Joseph Medical Center (SJMC) has added ... systems, major physician groups and health plans all cooperating ... patients. The health information exchange provides immediate access to ... throughout the continuum of services a patient receives. ... services to a broad cross section of the Houston ...
(Date:3/31/2015)... Vermont (PRWEB) March 31, 2015 Over ... articles about Shallow Water Blackout and conducted a survey ... the swimming community. , For additional information about Shallow ... Bob Bowman . To read the educational articles please ... survey also yielded many useful comments and personal stories ...
(Date:3/31/2015)... The growing concern over the Measles ... to protect themselves and their children. Meanwhile, millions ... and recovering from an ugly flu bug. One ... – Aero One ( http://www.aero1UV.com ) has launched the ... from the air but also kills airborne viruses and ...
(Date:3/31/2015)... 2015 India Network Foundation , ... a travel advisory to all USA bound international travelers ... United States are higher than many other countries and ... For example, a coronary artery bypass graft costs ... about $34,358 . Visitors are advised to get ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Filed by Southern Med Law Alleges Wife’s Death Resulted from Cancer Spread via Uterine Morcellation 2Health News:Power Morcellator Lawsuit Filed by Southern Med Law Alleges Wife’s Death Resulted from Cancer Spread via Uterine Morcellation 3Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:Startup Uses 3D-UV Technology to Take on Spring Allergies and Measles Virus 2Health News:Startup Uses 3D-UV Technology to Take on Spring Allergies and Measles Virus 3Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3
(Date:3/31/2015)... - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a ... products and a licensed producer ("LP") to cultivate marijuana ... Canada ) ("MMPR"), is pleased to announce that ... District of Saanich confirming the ... allows for commercial distribution of medical marijuana under the ...
(Date:3/31/2015)... AVIV, Israel, March 31, 2015  Galmed Pharmaceuticals ... biopharmaceutical company focused on the development and commercialization ... of liver diseases and cholesterol gallstones, today announced ... 31, 2014. Fourth Quarter 2014 Highlights: ... featuring a keynote address by Professor Rohit Loomba, ...
(Date:3/31/2015)... March 31, 2015   Unique Pharmaceuticals , a ... complete and the company has initiated sterile compounding operations ... goal as a company is to meet and exceed ... . "Meeting the new regulations is validation of our ... the future of our industry, investing in its continued ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
Cached News: